The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
22 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $9,038,945 in first-year total cost, median $381,657.
Most frequent study sections
- Diseases and Pathophysiology of the Visual System Study Section[DPVS]10
- Bioengineering of Neuroscience, Vision and Low Vision Technologies Study Section[BNVT]3
- Biology of the Visual System Study Section[BVS]2
- Chronic Dysfunction and Integrative Neurodegeneration Study Section[CDIN]1
- Drug Discovery for the Nervous System Study Section[DDNS]1
Most frequent institutions
- UNIVERSITY OF CALIFORNIA, SAN DIEGO2
- WASHINGTON UNIVERSITY2
- BAYLOR COLLEGE OF MEDICINE1
- CEDARS-SINAI MEDICAL CENTER1
- JACKSON LABORATORY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Identifying Shared Pathogenic Networks and Molecular Targets Underlying Retinal Pigmented Epithelial Associated Disease1R01EY027860-01 | CARTER, GREGORY WNISHINA, PATSY M | JACKSON LABORATORY, ME | $615,807 | DPVS |
| 2017 | Modulation of Lipid Bisretinoids Clearance with Beta-Cyclodextrins1R01EY027422-01 | NOCIARI, MARCELO M | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $507,404 | DPVS |
| 2017 | OCULAR DRUG DELIVERY NANOWAFER THERAPEUTIC TO TREAT CORNEAL NEOVASCULARIZATION1R01EY026950-01A1 | ACHARYA, GHANASHYAM S | BAYLOR COLLEGE OF MEDICINE, TX | $394,538 | GDD |
| 2016 | Therapeutic control of HSK by CD801R01EY026944-01 | GHIASI, HOMAYON | CEDARS-SINAI MEDICAL CENTER, CA | $393,750 | ZRG1 |
| 2016 | Nanogels for Drug Delivery across the BRB to Treat Diabetic Retinopathy1R01EY023853-01A1 | LOWE, TAO L | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $380,000 | ZRG1 |
| 2016 | Role of Host Cell Factors in Herpes Simplex Virus (HSV) Keratitis1R01EY023977-01A1 | LONGNECKER, RICHARD M | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $378,639 | DPVS |
| 2016 | Metabolic vulnerability as a disease target for glaucoma1R01EY026662-01 | INMAN, DENISE M | NORTHEAST OHIO MEDICAL UNIVERSITY, OH | $366,100 | DPVS |
| 2016 | DECIPHERING THE MECHANISTIC BASIS OF INFRARED VISION FOR OPTOGENETIC APPLICATIONS1R01EY026672-01 | CORBO, JOSEPH | WASHINGTON UNIVERSITY, MO | $343,125 | BVS |
| 2016 | Broad-band opsin and targeted optical-delivery for retinitis pigmentosa treatment1R01EY025717-01A1 | MOHANTY, SAMARENDRA KUMAR | NANOSCOPE TECHNOLOGIES, LLC, TX | $247,500 | BNVT |
| 2015 | Regulation of Retinal Cell Death in Diabetes2R01EY020582-06A1 | ABCOUWER, STEVEN FGARDNER, THOMAS W. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $571,370 | DPVS |
| 2015 | CONVERTING BIPOLAR CELLS INTO RED-SHIFTED OPTOGENETIC SENSORS FOR RETINAL THERAPY1R01EY024958-01 | CORBO, JOSEPHFLANNERY, JOHN GERARD | WASHINGTON UNIVERSITY, MO | $471,872 | BNVT |
| 2015 | A new molecular therapy against ocular herpes1R01EY024710-01A1 | SHUKLA, DEEPAK | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $399,521 | DPVS |
| 2015 | Molecular Therapies for Lebers Congenital Amaurosis Caused by KCNJ13 Mutations1R01EY024995-01A1 | PATTNAIK, BIKASH RANJAN | UNIVERSITY OF WISCONSIN-MADISON, WI | $378,260 | DPVS |
| 2015 | Necroptosis, neuroprotection and axonal regeneration in retina ganglion cell injury1R01EY025362-01 | VAVVAS, DEMETRIOS | MASSACHUSETTS EYE AND EAR INFIRMARY, MA | $369,000 | DPVS |
| 2015 | HTRA1 as a Therapeutic Target in the Treatment of Wet AMD1R01EY025693-01 | SHAW, PETER X | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $348,750 | ZRG1 |
| 2015 | Understanding how photoswitches restore visual function in blindness1R01EY024334-01A1 | KRAMER, RICHARD H | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $343,455 | NOIT |
| 2014 | A Novel Pharmacotherapy for Glaucoma1R01EY024717-01 | THAKUR, GANESH A | NORTHEASTERN UNIVERSITY, MA | $516,925 | DDNS |
| 2014 | Ataxin-7 oligonucleotide knock-down to treat SCA7 retinal and cerebellar disease1R01EY024747-01 | LA SPADA, ALBERT R | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $495,140 | CDIN |
| 2014 | Blockade of T-cell Co-Inhibitory Pathways & Immunotherapy to Prevent Ocular Herpe1R01EY024618-01 | BENMOHAMED, LBACHIR | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $386,250 | DPVS |
| 2014 | ECT Implants for Factor H Delivery in Models of AMD1R01EY024581-01 | ROHRER, BAERBEL | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $383,314 | BNVT |
| 2014 | Prevention of Retinal Degeneration by Transgenic Autologous Stem Cells1R01EY023968-01A1 | KATZ, MARTIN L | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $375,725 | DPVS |
| 2014 | Membrane Protein Transport in Photoreceptors2R01EY019298-06A1 | BAEHR, WOLFGANG | UNIVERSITY OF UTAH, UT | $372,500 | BVS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.